A reversed-phase HPLC-based method for the assay of cyclic nucleotide phosphodiesterase activity

被引：2

作者：

Abbott, BM

Thompson, PE

机构：

[1] Monash Univ, Victorian Coll Pharm, Dept Med Chem, Parkville, Vic 3052, Australia

[2] Monash Univ, Dept Med, Clayton, Vic 3128, Australia

[3] Kinacia Pty Ltd, Clayton, Vic 3128, Australia

来源：

ANALYTICAL BIOCHEMISTRY | 2005年 / 339卷 / 01期

基金：

澳大利亚研究理事会;

关键词：

D O I：

10.1016/j.ab.2004.12.014

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：185 / 187

页数：3

共 14 条

[1] PDE2 inhibition by the PI3 kinase inhibitor LY294002 and analogues [J].

Abbott, BM ;

Thompson, PE .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (11) :2847-2851

[2] DETERMINATION OF PHOSPHODIESTERASE ACTIVITY IN RAT MAST-CELLS USING THE FLUORESCENT CAMP ANALOG ANTHRANILOYL CAMP [J].

ALFONSO, A ;

ESTEVEZ, M ;

LOUZAO, MC ;

VIEYTES, MR ;

BOTANA, LM .

CELLULAR SIGNALLING, 1995, 7 (05) :513-518

[3] Phosphodiesterase 4 conformers: Preparation of recombinant enzymes and assay for inhibitors [J].

Bardelle, C ;

Smales, C ;

Ito, M ;

Nomoto, K ;

Wong, EYM ;

Kato, H ;

Saeki, T ;

Staddon, JM .

ANALYTICAL BIOCHEMISTRY, 1999, 275 (02) :148-155

[4] Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A [J].

Fawcett, L ;

Baxendale, R ;

Stacey, P ;

McGrouther, C ;

Harrow, I ;

Soderling, S ;

Hetman, J ;

Beavo, JA ;

Phillips, SC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) :3702-3707

[5] Differential inhibition of multiple cAMP phosphodiesterase isozymes by isoflavones and tyrphostins [J].

Nichols, MR ;

Morimoto, BH .

MOLECULAR PHARMACOLOGY, 2000, 57 (04) :738-745

[6]

Ogata S., 1995, JPN J ORAL BIOL, V37, P1, DOI 10.2330/joralbiosci1965.37.1

[7] Chemotherapeutic potential of phosphodiesterase inhibitors [J].

Perry, MJ ;

Higgs, GA .

CURRENT OPINION IN CHEMICAL BIOLOGY, 1998, 2 (04) :472-481

[8] ISOZYME-SELECTIVE INHIBITION OF CGMP-STIMULATED CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES BY ERYTHRO-9-(2-HYDROXY-3-NONYL) ADENINE [J].

PODZUWEIT, T ;

NENNSTIEL, P ;

MULLER, A .

CELLULAR SIGNALLING, 1995, 7 (07) :733-738

[9]

Post Sr, 2000, METH MOL B, V136, P363

[10] Characterization of a novel phosphodiesterase type 5 inhibitor: JNJ-10258859 [J].

Qiu, YH ;

Bhattacharjee, S ;

Kraft, P ;

John, TM ;

Craig, E ;

Haynes-Johnson, D ;

Guan, JH ;

Jiang, WQ ;

Macielag, M ;

Sui, ZH ;

Clancy, J ;

Lundeen, S .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2003, 472 (1-2) :73-80

← 1 2 →